The prognostic significance of additional localized treatment to primary lesion in patients undergoing hormone therapy for metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.
Yuta YamadaNobuyoshi KosakaShoji KimuraKosuke IwataniNaoki KimuraJun MikiTakahiro KimuraHaruki KumePublished in: PloS one (2024)
LT to the primary lesion in metastatic hormone-sensitive prostate cancer may provide prognostic benefits and especially in patients with low tumor burden.